Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Laser safety in fiber-optic monitoring of spinal cord hemodynamics: a preclinical evaluation.

Busch DR, Davis J, Kogler A, Galler RM, Parthasarathy AB, Yodh AG, Floyd TF.

J Biomed Opt. 2018 Jun;23(6):1-9. doi: 10.1117/1.JBO.23.6.065003.

PMID:
29923371
2.

Neurosurgery in East Africa: Innovations.

Budohoski KP, Ngerageza JG, Austard B, Fuller A, Galler R, Haglund M, Lett R, Lieberman IH, Mangat HS, March K, Olouch-Olunya D, Piquer J, Qureshi M, Santos MM, Schöller K, Shabani HK, Trivedi RA, Young P, Zubkov MR, Härtl R, Stieg PE.

World Neurosurg. 2018 May;113:436-452. doi: 10.1016/j.wneu.2018.01.085. Review.

PMID:
29702967
3.

Pneumococcal Predictive Proteins Selected by Microbial Genomic Approach Are Serotype Cross-Reactive and Bind to Host Extracellular Matrix Proteins.

Argondizzo APC, Rocha-de-Souza CM, de Almeida Santiago M, Galler R, Reis JN, Medeiros MA.

Appl Biochem Biotechnol. 2017 Aug;182(4):1518-1539. doi: 10.1007/s12010-017-2415-6. Epub 2017 Feb 17.

PMID:
28211009
4.

Solubility as a limiting factor for expression of hepatitis A virus proteins in insect cell-baculovirus system.

Silva HC Junior, Pestana CP, Galler R, Medeiros MA.

Mem Inst Oswaldo Cruz. 2016 Aug;111(8):535-8. doi: 10.1590/0074-02760160153. Epub 2016 Jul 11.

5.

Fiber-optic Monitoring of Spinal Cord Hemodynamics in Experimental Aortic Occlusion.

Kogler AS, Bilfinger TV, Galler RM, Mesquita RC, Cutrone M, Schenkel SS, Yodh AG, Floyd TF.

Anesthesiology. 2015 Dec;123(6):1362-73. doi: 10.1097/ALN.0000000000000883.

6.

Generation and Characterization of Murine Monoclonal Antibodies anti-PBP2a of Methicillin-resistant Staphylococcus aureus.

Senna JP, Teixeira Mda G, Santiago Mde A, Batoréu NM, Valadares N, Galler R.

Monoclon Antib Immunodiagn Immunother. 2015 Aug;34(4):257-62. doi: 10.1089/mab.2015.0013.

PMID:
26301929
7.

Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.

Martins MA, Tully DC, Cruz MA, Power KA, Veloso de Santana MG, Bean DJ, Ogilvie CB, Gadgil R, Lima NS, Magnani DM, Ejima K, Allison DB, Piatak M Jr, Altman JD, Parks CL, Rakasz EG, Capuano S 3rd, Galler R, Bonaldo MC, Lifson JD, Allen TM, Watkins DI.

J Virol. 2015 Nov;89(21):10802-20. doi: 10.1128/JVI.01440-15. Epub 2015 Aug 19.

8.

A DNA vaccine against yellow fever virus: development and evaluation.

Maciel M Jr, Cruz Fda S, Cordeiro MT, da Motta MA, Cassemiro KM, Maia Rde C, de Figueiredo RC, Galler R, Freire Mda S, August JT, Marques ET, Dhalia R.

PLoS Negl Trop Dis. 2015 Apr 13;9(4):e0003693. doi: 10.1371/journal.pntd.0003693. eCollection 2015 Apr.

9.

Identification of proteins in Streptococcus pneumoniae by reverse vaccinology and genetic diversity of these proteins in clinical isolates.

Argondizzo AP, da Mota FF, Pestana CP, Reis JN, de Miranda AB, Galler R, Medeiros MA.

Appl Biochem Biotechnol. 2015 Feb;175(4):2124-65. doi: 10.1007/s12010-014-1375-3. Epub 2014 Dec 2.

PMID:
25448632
10.

Evaluation of pre-induction temperature, cell growth at induction and IPTG concentration on the expression of a leptospiral protein in E. coli using shaking flasks and microbioreactor.

Larentis AL, Nicolau JF, Esteves Gdos S, Vareschini DT, de Almeida FV, dos Reis MG, Galler R, Medeiros MA.

BMC Res Notes. 2014 Sep 25;7:671. doi: 10.1186/1756-0500-7-671.

11.

Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline.

Campi-Azevedo AC, de Almeida Estevam P, Coelho-Dos-Reis JG, Peruhype-Magalhães V, Villela-Rezende G, Quaresma PF, Maia Mde L, Farias RH, Camacho LA, Freire Mda S, Galler R, Yamamura AM, Almeida LF, Lima SM, Nogueira RM, Silva Sá GR, Hokama DA, de Carvalho R, Freire RA, Filho EP, Leal Mda L, Homma A, Teixeira-Carvalho A, Martins RM, Martins-Filho OA.

BMC Infect Dis. 2014 Jul 15;14:391. doi: 10.1186/1471-2334-14-391.

12.

Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.

Martins MA, Wilson NA, Piaskowski SM, Weisgrau KL, Furlott JR, Bonaldo MC, Veloso de Santana MG, Rudersdorf RA, Rakasz EG, Keating KD, Chiuchiolo MJ, Piatak M Jr, Allison DB, Parks CL, Galler R, Lifson JD, Watkins DI.

J Virol. 2014 Jul;88(13):7493-516. doi: 10.1128/JVI.00601-14. Epub 2014 Apr 16.

13.

Improved genetic stability of recombinant yellow fever 17D virus expressing a lentiviral Gag gene fragment.

de Santana MG, Neves PC, dos Santos JR, Lima NS, dos Santos AA, Watkins DI, Galler R, Bonaldo MC.

Virology. 2014 Mar;452-453:202-11. doi: 10.1016/j.virol.2014.01.017. Epub 2014 Feb 8.

14.

The yellow fever 17D virus as a platform for new live attenuated vaccines.

Bonaldo MC, Sequeira PC, Galler R.

Hum Vaccin Immunother. 2014;10(5):1256-65. doi: 10.4161/hv.28117. Epub 2014 Feb 19. Review.

15.
16.

Optical monitoring and detection of spinal cord ischemia.

Mesquita RC, D'Souza A, Bilfinger TV, Galler RM, Emanuel A, Schenkel SS, Yodh AG, Floyd TF.

PLoS One. 2013 Dec 16;8(12):e83370. doi: 10.1371/journal.pone.0083370. eCollection 2013.

17.

Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses.

Neves PC, Santos JR, Tubarão LN, Bonaldo MC, Galler R.

PLoS One. 2013 Dec 6;8(12):e81953. doi: 10.1371/journal.pone.0081953. eCollection 2013.

18.

Correction: Recombinant Yellow Fever Viruses Elicit CD8+ T Cell Responses and Protective Immunity against Trypanosoma cruzi.

Nogueira RT, Nogueira AR, Pereira MCS, Rodrigues MM, Neves PCDC, Galler R, Bonaldo MC.

PLoS One. 2013 Nov 8;8(11). doi: 10.1371/annotation/39b41d98-b117-41cf-b5de-b8486a67b1cd. eCollection 2013.

19.

Identification of seroreactive proteins of Leptospira interrogans serovar copenhageni using a high-density protein microarray approach.

Lessa-Aquino C, Borges Rodrigues C, Pablo J, Sasaki R, Jasinskas A, Liang L, Wunder EA Jr, Ribeiro GS, Vigil A, Galler R, Molina D, Liang X, Reis MG, Ko AI, Medeiros MA, Felgner PL.

PLoS Negl Trop Dis. 2013 Oct 17;7(10):e2499. doi: 10.1371/journal.pntd.0002499. eCollection 2013.

20.

Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi.

Nogueira RT, Nogueira AR, Pereira MC, Rodrigues MM, Neves PC, Galler R, Bonaldo MC.

PLoS One. 2013;8(3):e59347. doi: 10.1371/journal.pone.0059347. Epub 2013 Mar 19. Erratum in: PLoS One. 2013 Nov 8;8(11):null.

21.

The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue.

Azevedo AS, Gonçalves AJ, Archer M, Freire MS, Galler R, Alves AM.

PLoS One. 2013;8(3):e58357. doi: 10.1371/journal.pone.0058357. Epub 2013 Mar 5.

22.

17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.

Martins RM, Maia Mde L, Farias RH, Camacho LA, Freire MS, Galler R, Yamamura AM, Almeida LF, Lima SM, Nogueira RM, Sá GR, Hokama DA, de Carvalho R, Freire RA, Pereira Filho E, Leal Mda L, Homma A.

Hum Vaccin Immunother. 2013 Apr;9(4):879-88. doi: 10.4161/hv.22982. Epub 2013 Jan 30.

23.

Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.

Martins MA, Bonaldo MC, Rudersdorf RA, Piaskowski SM, Rakasz EG, Weisgrau KL, Furlott JR, Eernisse CM, Veloso de Santana MG, Hidalgo B, Friedrich TC, Chiuchiolo MJ, Parks CL, Wilson NA, Allison DB, Galler R, Watkins DI.

PLoS One. 2013;8(1):e54434. doi: 10.1371/journal.pone.0054434. Epub 2013 Jan 15.

24.

17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.

Campi-Azevedo AC, de Araújo-Porto LP, Luiza-Silva M, Batista MA, Martins MA, Sathler-Avelar R, da Silveira-Lemos D, Camacho LA, de Menezes Martins R, de Lourdes de Sousa Maia M, Farias RH, da Silva Freire M, Galler R, Homma A, Ribeiro JG, Lemos JA, Auxiliadora-Martins M, Caldas IR, Elói-Santos SM, Teixeira-Carvalho A, Martins-Filho OA.

PLoS One. 2012;7(12):e49828. doi: 10.1371/journal.pone.0049828. Epub 2012 Dec 10.

25.

Vaccine-induced CD8+ T cells control AIDS virus replication.

Mudd PA, Martins MA, Ericsen AJ, Tully DC, Power KA, Bean AT, Piaskowski SM, Duan L, Seese A, Gladden AD, Weisgrau KL, Furlott JR, Kim YI, Veloso de Santana MG, Rakasz E, Capuano S 3rd, Wilson NA, Bonaldo MC, Galler R, Allison DB, Piatak M Jr, Haase AT, Lifson JD, Allen TM, Watkins DI.

Nature. 2012 Nov 1;491(7422):129-33. doi: 10.1038/nature11443. Epub 2012 Sep 30.

26.

Retention of a recombinant GFP protein expressed by the yellow fever 17D virus in the E/NS1 intergenic region in the endoplasmic reticulum.

Trindade GF, Santana MG, Santos JR, Galler R, Bonaldo MC.

Mem Inst Oswaldo Cruz. 2012 Mar;107(2):262-72.

27.

Optimization of medium formulation and seed conditions for expression of mature PsaA (pneumococcal surface adhesin A) in Escherichia coli using a sequential experimental design strategy and response surface methodology.

Larentis AL, Nicolau JF, Argondizzo AP, Galler R, Rodrigues MI, Medeiros MA.

J Ind Microbiol Biotechnol. 2012 Jun;39(6):897-908. doi: 10.1007/s10295-012-1099-8. Epub 2012 Feb 25.

PMID:
22366767
28.

The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages.

Vojnov L, Martins MA, Bean AT, Veloso de Santana MG, Sacha JB, Wilson NA, Bonaldo MC, Galler R, Stevenson M, Watkins DI.

J Virol. 2012 Apr;86(8):4682-7. doi: 10.1128/JVI.06324-11. Epub 2012 Feb 8.

29.

Dengue vaccines: closer but not there yet.

Galler R, Bonaldo MC, Alves AM.

Mem Inst Oswaldo Cruz. 2011 Dec;106(8):905-6. No abstract available.

30.

Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles.

Gandini M, Reis SR, Torrentes-Carvalho A, Azeredo EL, Freire Mda S, Galler R, Kubelka CF.

Mem Inst Oswaldo Cruz. 2011 Aug;106(5):594-605.

31.

GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo.

Vojnov L, Martins MA, Almeida JR, Ende Z, Rakasz EG, Reynolds MR, Leon EJ, Weisgrau KL, Burwitz BJ, Folkvord JM, de Santana MG, Neves PC, Connick E, Skinner PJ, Gostick E, O'Connor DH, Wilson NA, Bonaldo MC, Galler R, Price DA, Douek DC, Watkins DI.

PLoS One. 2011;6(8):e23515. doi: 10.1371/journal.pone.0023515. Epub 2011 Aug 26.

32.

Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody.

Luiza-Silva M, Campi-Azevedo AC, Batista MA, Martins MA, Avelar RS, da Silveira Lemos D, Bastos Camacho LA, de Menezes Martins R, de Lourdes de Sousa Maia M, Guedes Farias RH, da Silva Freire M, Galler R, Homma A, Leite Ribeiro JG, Campos Lemos JA, Auxiliadora-Martins M, Eloi-Santos SM, Teixeira-Carvalho A, Martins-Filho OA.

J Infect Dis. 2011 Sep 15;204(6):873-83. doi: 10.1093/infdis/jir439.

PMID:
21849284
33.

DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.

Azevedo AS, Yamamura AM, Freire MS, Trindade GF, Bonaldo M, Galler R, Alves AM.

PLoS One. 2011;6(7):e20528. doi: 10.1371/journal.pone.0020528. Epub 2011 Jul 11.

34.
35.

Cloning and optimization of induction conditions for mature PsaA (pneumococcal surface adhesin A) expression in Escherichia coli and recombinant protein stability during long-term storage.

Larentis AL, Argondizzo AP, Esteves Gdos S, Jessouron E, Galler R, Medeiros MA.

Protein Expr Purif. 2011 Jul;78(1):38-47. doi: 10.1016/j.pep.2011.02.013. Epub 2011 Mar 6.

PMID:
21362478
36.

Interaction between the yellow fever virus nonstructural protein NS3 and the host protein Alix contributes to the release of infectious particles.

Carpp LN, Galler R, Bonaldo MC.

Microbes Infect. 2011 Jan;13(1):85-95. doi: 10.1016/j.micinf.2010.10.010. Epub 2010 Oct 29.

37.

CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5-7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses.

Neves PC, Rudersdorf RA, Galler R, Bonaldo MC, de Santana MG, Mudd PA, Martins MA, Rakasz EG, Wilson NA, Watkins DI.

Vaccine. 2010 Nov 29;28(51):8183-8. doi: 10.1016/j.vaccine.2010.09.090. Epub 2010 Oct 25.

38.

The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques--implications for recombinant vaccine design.

Mudd PA, Piaskowski SM, Neves PC, Rudersdorf R, Kolar HL, Eernisse CM, Weisgrau KL, de Santana MG, Wilson NA, Bonaldo MC, Galler R, Rakasz EG, Watkins DI.

Immunogenetics. 2010 Sep;62(9):593-600. doi: 10.1007/s00251-010-0461-0. Epub 2010 Jul 7.

39.

Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques.

Bonaldo MC, Martins MA, Rudersdorf R, Mudd PA, Sacha JB, Piaskowski SM, Costa Neves PC, Veloso de Santana MG, Vojnov L, Capuano S 3rd, Rakasz EG, Wilson NA, Fulkerson J, Sadoff JC, Watkins DI, Galler R.

J Virol. 2010 Apr;84(7):3699-706. doi: 10.1128/JVI.02255-09. Epub 2010 Jan 20.

40.

Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination.

Silva ML, Espírito-Santo LR, Martins MA, Silveira-Lemos D, Peruhype-Magalhães V, Caminha RC, de Andrade Maranhão-Filho P, Auxiliadora-Martins M, de Menezes Martins R, Galler R, da Silva Freire M, Marcovistz R, Homma A, Teuwen DE, Elói-Santos SM, Andrade MC, Teixeira-Carvalho A, Martins-Filho OA.

Clin Vaccine Immunol. 2010 Jan;17(1):118-26. doi: 10.1128/CVI.00369-09. Epub 2009 Nov 11.

41.

TLR expression and NK cell activation after human yellow fever vaccination.

Neves PC, Matos DC, Marcovistz R, Galler R.

Vaccine. 2009 Sep 18;27(41):5543-9. doi: 10.1016/j.vaccine.2009.07.028. Epub 2009 Jul 30.

PMID:
19647065
42.

Effects of hydrostatic pressure on the stability and thermostability of poliovirus: a new method for vaccine preservation.

Ferreira E, Mendes YS, Silva JL, Galler R, Oliveira AC, Freire MS, Gaspar LP.

Vaccine. 2009 Aug 27;27(39):5332-7. doi: 10.1016/j.vaccine.2009.06.099. Epub 2009 Jul 17.

PMID:
19616496
43.

Generation of monoclonal antibodies against human recombinant interferon beta using genetic immunization with simultaneous expression of IgM and IgG isotypes.

Cantelli CP, da Glória Martins Teixeira M, Santos EA, da Silva HC, da Silva E Mouta S, Pimenta MM, Vianna CO, de Souza NP, Batoreu NM, Galler R, de Moraes MT.

Hybridoma (Larchmt). 2009 Jun;28(3):211-4. doi: 10.1089/hyb.2008.0094.

PMID:
19519248
44.

Evidence for interferon production and its correlation with YF 17DD vaccine virus yields in primary chick embryo cells.

Caride E, Borges MB, Marcovistz R, Galler R, Freire Mda S.

Virus Res. 2008 Oct;137(1):106-11. doi: 10.1016/j.virusres.2008.06.007. Epub 2008 Jul 30.

PMID:
18621087
45.

Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys.

Trindade GF, Marchevsky RS, Fillipis AM, Nogueira RM, Bonaldo MC, Acero PC, Caride E, Freire MS, Galler R.

An Acad Bras Cienc. 2008 Jun;80(2):311-21.

46.

Pressure-inactivated yellow fever 17DD virus: implications for vaccine development.

Gaspar LP, Mendes YS, Yamamura AM, Almeida LF, Caride E, Gonçalves RB, Silva JL, Oliveira AC, Galler R, Freire MS.

J Virol Methods. 2008 Jun;150(1-2):57-62. doi: 10.1016/j.jviromet.2008.03.002.

PMID:
18420285
47.

Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures.

Borges MB, Caride E, Jabor AV, Malachias JM, Freire MS, Homma A, Galler R.

Virus Genes. 2008 Feb;36(1):35-44. Epub 2007 Nov 27.

PMID:
18040767
48.

Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes.

Bonaldo MC, Mello SM, Trindade GF, Rangel AA, Duarte AS, Oliveira PJ, Freire MS, Kubelka CF, Galler R.

Virol J. 2007 Oct 30;4:115.

49.

Biomechanical comparison of instrumented and uninstrumented multilevel cervical discectomy versus corpectomy.

Galler RM, Dogan S, Fifield MS, Bozkus H, Chamberlain RH, Sonntag VK, Crawford NR.

Spine (Phila Pa 1976). 2007 May 15;32(11):1220-6.

PMID:
17495779
50.

Wild dengue virus types 1, 2 and 3 viremia in rhesus monkeys.

Freire M, Marchevsky R, Almeida L, Yamamura A, Caride E, Brindeiro P, Motta M, Nogueira R, Kubelka C, Bonaldo M, Galler R.

Mem Inst Oswaldo Cruz. 2007 May;102(2):203-8.

Supplemental Content

Loading ...
Support Center